Correlation Between ESSA Pharma and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and Atea Pharmaceuticals, you can compare the effects of market volatilities on ESSA Pharma and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Atea Pharmaceuticals.
Diversification Opportunities for ESSA Pharma and Atea Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ESSA and Atea is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between ESSA Pharma and Atea Pharmaceuticals
Given the investment horizon of 90 days ESSA Pharma is expected to under-perform the Atea Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, ESSA Pharma is 2.83 times less risky than Atea Pharmaceuticals. The stock trades about -0.45 of its potential returns per unit of risk. The Atea Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 330.00 in Atea Pharmaceuticals on September 27, 2024 and sell it today you would lose (5.00) from holding Atea Pharmaceuticals or give up 1.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ESSA Pharma vs. Atea Pharmaceuticals
Performance |
| Timeline |
| ESSA Pharma |
| Atea Pharmaceuticals |
ESSA Pharma and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ESSA Pharma and Atea Pharmaceuticals
The main advantage of trading using opposite ESSA Pharma and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| ESSA Pharma vs. Altamira Therapeutics | ESSA Pharma vs. Summit Therapeutics PLC | ESSA Pharma vs. Avenue Therapeutics | ESSA Pharma vs. Spero Therapeutics |
| Atea Pharmaceuticals vs. Oric Pharmaceuticals | Atea Pharmaceuticals vs. Lyra Therapeutics | Atea Pharmaceuticals vs. Inhibrx | Atea Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |